Drawing for EGLS

USPTO serial 79340854

EGLS

Reviewed by CopyMark Law Group

Reg. 7209461Status 700Registered
Filing date
Status date
Registration date
Nov 7, 2023
Examiner
KUHN, RIO NICE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EGLS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009System comprising software and user interface for monitoring health information in acute care medicine used in conjunction with a health monitoring device; software as a medical device [ SaMD ], downloadable for use analyzing, generating, optimizing, displaying, and interpreting images for use with medical diagnostic imaging equipmentACTIVE—
010A medical device, namely, a health monitoring device for taking ultrasound images used in acute care medicineACTIVE—
041Teaching and training of an application method for performing ultrasound scans in the medical field for physicians, namely, conducting seminars, workshops and conferences in the field of medical devicesACTIVE—
042Hosting websites of others on the Internet and providing an online non-downloadable software education and e-learning platform for presenting information for medical teaching and training; design and development of computer software; customizing computer software; software development in the field of healthcare; software as a service (SaaS) services featuring software for monitoring, reporting on, and analyzing the use of the monitoring of health information; providing temporary use of online non-downloadable software application for patient information tracking; consultancy, advisory and information services relating to or connected with all the aforementioned services; research, design, development and engineering of medical devices and software; creating, design, installation, implementation, maintenance and updating of medical software; design and development of medical devices and software; design, creation, implementation, installation, maintenance and updating of medical software; medical research; scientific, technological and medical research in the field of medical device diagnostics and monitoring; research and development in the field of medicine; engineering services in the field of medical devices; scientific and technological research and design relating to the medical device industry; design and development of computer hardware and software in the medical device industry; scientific and technical research in the field of medical device diagnostic and monitoringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 4, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 8, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 8, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 7, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 12, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 7, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 25, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 25, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 22, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 2, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 2, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 2, 2023NPUBNOTICE OF PUBLICATION—
Jul 19, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 22, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 29, 2022RFNTREFUSAL PROCESSED BY IB—
Dec 5, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 5, 2022RFRRREFUSAL PROCESSED BY MPU—
Sep 22, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 21, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2022DOCKASSIGNED TO EXAMINER—
Jun 4, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 24, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 20, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance